Endometriosis: Undervalued Research Pointing to the Disease's Epigenetic Roots

The Tia Take

Endometriosis is a chronic inflammatory condition whose growth is fueled by the hormone estrogen. It affects a significant portion of the global population, impacting an estimated 5-10% of reproductive-aged women, which translates to roughly 190 million individuals.¹ This often debilitating disease is defined by the presence of tissue that is similar to the uterine lining (the endometrium) but is found growing outside the uterus. These growths, or lesions, most commonly appear on the pelvic peritoneum (the lining of the abdominal cavity), the ovaries, and the deep space between the rectum and vagina. They are a primary cause of severe chronic pelvic pain, profoundly painful periods (dysmenorrhea), painful intercourse (dyspareunia), and, in many cases, infertility.¹

Despite how common it is and the significant toll it takes on quality of life—leading to fatigue, depression, and anxiety—the fundamental origins of endometriosis have remained a puzzle for centuries.²

For decades, the prevailing explanation was the theory of retrograde menstruation, proposed by John A. Sampson in 1927.⁶ This model suggested that during a menstrual period, some endometrial cells flow backward through the fallopian tubes and into the pelvic cavity, where they can implant on organs and grow.¹ While this theory is compelling, it fails to explain key clinical observations, such as endometriosis found in girls before their first period, in males, or in distant locations like the lungs and heart.¹

A major shift in thinking began in the 1980s, championed by researchers like Ronald Batt, who proposed the Müllerianosis theory.²² This theory posits an in utero origin, meaning the disease begins during fetal development. It suggests that small clusters of embryonic tissue that are destined to form the reproductive tract (Müllerian tissue) are misplaced in other parts of the body.²⁰ This perspective not only changes our functional understanding of the disease but also points toward a powerful underlying cause: an epigenetic mechanism. Epigenetics refers to changes in how genes are expressed without altering the DNA code itself—like software instructions telling the body’s hardware which genes to turn on or off. This idea is supported by findings of misplaced endometrial tissue in human fetuses and helps explain why the disease often runs in families.²

Today, cutting-edge research confirms that endometriosis is not caused by a single factor but is a multifactorial disease. It involves a complex interplay of genetic predisposition, these epigenetic modifications, immune system dysfunction, and abnormal stem cell activity.² This modern view provides a more complete framework for understanding the disease's varied symptoms, its chronic nature, and why it so often resists treatment.

Current therapies are primarily aimed at managing symptoms. They typically involve hormonal medications to suppress the growth of lesions or surgery to remove them.⁹ While these methods can provide significant pain relief, they do not offer a permanent cure, and symptoms often return.⁹ This highlights a critical need for new strategies that move beyond symptom management to address the disease's developmental and molecular roots, aiming for more fundamental and lasting solutions.

Introduction to Endometriosis: A Persistent Enigma

Endometriosis represents a major challenge in women's health. It is characterized by tissue resembling the endometrium—the glands and stroma that normally line the uterus—growing in locations outside the uterine cavity.¹ This condition is remarkably common, affecting an estimated 190 million individuals worldwide.¹ While most often found in the pelvis, there are documented cases of this tissue appearing in the lungs, heart, and even the brain. These strange findings lead researchers to question how this could happen. It seems highly unlikely that, per Sampson's hypothesis, uterine tissue could travel from the enclosed pelvic cavity to distant organs throughout the body. So, what is truly happening?

The clinical symptoms of endometriosis are diverse and often debilitating. The classic signs include chronic inflammation, severe pelvic pain—which can manifest as painful periods, painful intercourse, and persistent non-menstrual pain—and a strong link to infertility.¹ This ectopic tissue behaves like the normal endometrium: it responds to the monthly hormonal cycle, growing under the influence of estrogen and breaking down when hormone levels fall. However, with no way to exit the body, this process causes internal bleeding, leading to chronic inflammation, the formation of scar tissue (adhesions), and intense pain.¹

Despite its prevalence, endometriosis is notoriously difficult to diagnose, with patients often suffering for an average of 4 to 11 years before receiving a definitive diagnosis.³⁶ This delay contributes to prolonged suffering and allows the disease to potentially become more severe.

The multifaceted nature of endometriosis—with its varied symptoms, lesion locations, and resistance to standard treatments—underscores the urgent need to understand its etiology (its cause) and pathogenesis (how it develops).⁷ Unraveling the fundamental mechanisms is the only way to develop more effective, targeted, and ultimately curative therapies.

Historical Understanding of Endometriosis: From Observation to Theory

The journey to understand endometriosis has spanned centuries, marked by evolving theories.

Early Descriptions

The earliest descriptions of symptoms consistent with endometriosis date back to 1690.¹³ In 1860, the pathologist Karl von Rokitansky was the first to microscopically identify the condition, defining it as active endometrium outside the uterus.⁶ His contemporary, Thomas Cullen, provided detailed descriptions of these ectopic tissues in various pelvic sites and was among the first to propose that different manifestations of the disease shared a common origin.¹² The term "endometriosis" was finally coined and standardized by John Albertson Sampson in 1927, marking a pivotal moment in the formal study of the disease.⁶

Sampson's Retrograde Menstruation Theory (1927): The Foundational Model

John A. Sampson provided the first widely accepted theory of how endometriosis develops. He observed during surgery that his patients' ectopic lesions bled at the same time as their menstruation, confirming their endometrial origin.⁶ In 1927, he proposed his theory of retrograde menstruation.¹ This theory posits that menstrual blood containing living endometrial cells flows backward through the fallopian tubes and into the pelvic cavity, where the cells can implant on organs and grow into lesions.⁶

Sampson’s theory became the dominant explanation for decades because it logically explained why lesions are most common in the pelvis.⁵ However, despite its influence, the theory has several significant limitations:

Prevalence vs. Incidence: Retrograde menstruation is a nearly universal phenomenon, occurring in up to 90% of menstruating women.¹³ Yet, only a minority develop endometriosis, suggesting that backward flow alone is not enough to cause the disease.
Atypical Populations: The theory cannot account for endometriosis found in girls who have not yet started menstruating (pre-menarchal), in males who lack a uterus, or in individuals born without a uterus (a condition known as Müllerian agenesis).¹, ⁵
Extra-Pelvic Lesions: A major challenge is the presence of endometriosis in distant sites like the lungs, diaphragm, and brain. It is difficult to explain how menstrual cells could travel from the pelvis to these remote locations.¹
Genetic Link: The theory does not explain the strong tendency for endometriosis to run in families (familial aggregation), which points to an underlying genetic predisposition.²

These unanswered questions created a need for alternative theories to build a more complete picture.

The Paradigm Shift: Developmental Origins (1980s and Beyond)

The gaps in Sampson's theory pushed researchers to explore new ideas, leading to a paradigm shift that focused on developmental origins.

Alternative Theories

Two key theories emerged to explain what retrograde menstruation could not:

Coelomic Metaplasia Theory: This theory proposes that endometriosis does not come from the uterus at all. Instead, it suggests that certain cells already present throughout the body can transform—a process called metaplasia—into endometrial-like tissue. The source is thought to be the coelomic epithelium, an embryonic tissue layer that forms the lining of the abdominal and pelvic cavities. Under specific triggers, like hormonal or inflammatory signals, these versatile cells could differentiate into endometriosis, allowing lesions to arise de novo (anew) in various locations.
Müllerianosis Theory: The In Utero Origin: This theory, central to our modern understanding, argues that endometriosis originates during embryonic development. Championed by Dr. Ronald Batt, the Müllerianosis theory defines endometriosis as a choristoma—a collection of normal tissue found in an abnormal location due to a developmental error.²⁰, ²² The theory suggests that during the formation of the fetus, small clusters of Müllerian tissue (the embryonic precursor to the fallopian tubes, uterus, and cervix) are misplaced. These "rests" of tissue can end up in other organs throughout the body.¹⁸ They may lie dormant for years, only to be activated at puberty by the rise of estrogen, at which point they grow into endometriotic lesions.⁵

Evidence for the Müllerianosis Theory

This developmental theory offers powerful explanations for the puzzles that Sampson's theory could not solve:

Fetal Evidence: Researchers have found direct proof for this concept. Studies have identified ectopic endometrial tissue in human female fetuses, confirming that the misplacement of this tissue can indeed happen before birth.¹⁸
Extra-Pelvic Lesions: Müllerianosis provides a clear mechanism for endometriosis in distant organs. If the embryonic cells were misplaced during organogenesis (the formation of organs), they could have been distributed throughout the body, explaining lesions in the lungs, heart, and diaphragm.¹
Atypical Cases: The theory accounts for endometriosis in males (who have Müllerian ducts early in development) and in pre-menarchal girls, as the misplaced tissue would be present from birth.¹, ⁵
Familial Link: A developmental origin aligns perfectly with the observation that endometriosis runs in families, as genetic factors could easily influence such embryonic processes.¹

Cutting-Edge Research: A Multifactorial Disease

Modern science views endometriosis not as a disease with a single cause, but as a complex condition arising from the intersection of several factors.

Genetic Predisposition

Endometriosis is a heritable condition. Studies show that first-degree relatives of an affected individual have a significantly higher risk of developing the disease.²⁷ Its inheritance pattern is considered polygenic/multifactorial, meaning it is determined by the combined effects of multiple genes interacting with environmental factors, not a single "endometriosis gene."²⁶ A large-scale global study identified 42 distinct regions in our DNA that increase the risk of endometriosis, with some genes linked to pain perception, providing a biological basis for the chronic pain associated with the disease.²

Epigenetic Modifications

Beyond the DNA code itself, epigenetic factors play a pivotal role. These are molecular changes that act on top of the genetic code to regulate which genes are turned on or off.

DNA Methylation: Think of this as a biological "dimmer switch" for genes. In endometriosis, abnormal methylation patterns are common. Some genes that should be off are turned on, and vice versa, disrupting normal cellular functions and promoting the survival of lesions.¹⁶
Histone Modifications: If DNA is the thread, histones are the spools it wraps around. Modifying these spools can make the DNA tighter or looser, controlling which genes can be read and activated. In endometriosis, these modifications can promote uncontrolled cell proliferation.¹⁶
Non-coding RNAs: These molecules act as fine-tuning regulators, and their dysregulation in endometriosis has been linked to inflammation, tissue fibrosis, and progesterone resistance.³⁴

Immune System Dysfunction

Chronic inflammation is a core feature of endometriosis.³ The immune system, which should recognize and eliminate misplaced cells, fails to do so. In fact, it often contributes to the problem.

Immune Cell Failure: Key defensive cells, like Natural Killer (NK) cells that are supposed to destroy abnormal tissue, show reduced activity.²⁹
Pro-inflammatory Environment: Other immune cells, like macrophages, gather at the lesions but instead of cleaning them up, they release inflammatory signals (cytokines) that fuel pain, inflammation, and the growth of new blood vessels to feed the lesions.²⁹

This creates a self-perpetuating cycle of inflammation that allows the disease to persist.

Hormonal Dysregulation

Endometriosis is fundamentally estrogen-dependent. Its growth is driven by estrogen.

Local Estrogen Production: Endometriotic lesions have the unique and harmful ability to produce their own estrogen, creating their own fuel source for growth.⁷
Progesterone Resistance: A crucial aspect of the disease is that this tissue is often resistant to progesterone, a hormone that normally calms inflammation and balances estrogen's effects.⁵ This resistance, often caused by epigenetic changes, allows the lesions to survive and thrive even when progesterone is present.

Current Treatments and Their Mechanisms of Action

There is currently no cure for endometriosis. Treatments focus on managing pain, slowing the growth of lesions, and addressing infertility.⁹

Hormonal Therapies

The goal of hormonal therapy is to create a low-estrogen environment to "starve" the lesions and induce their atrophy (shrinking).

Oral Contraceptives and Progestins: These are first-line treatments that suppress ovulation and reduce the hormonal stimulation of lesions.⁹, ¹⁷
GnRH Agonists and Antagonists: These powerful drugs shut down estrogen production from the ovaries, inducing a temporary, reversible menopause. They are highly effective for severe pain but can cause significant side effects like hot flashes and bone density loss.¹⁷
Aromatase Inhibitors: These drugs block the enzyme that produces estrogen, targeting not only the ovaries but also the local estrogen production within the lesions themselves.¹⁷

Surgical Treatments

Surgery aims to physically remove the disease.

Laparoscopy: This minimally invasive surgery is the gold standard for both diagnosis and treatment. Surgeons can either excise (cut out) the lesions or ablate (destroy) them with heat or laser energy.³⁵
Hysterectomy: The surgical removal of the uterus, sometimes along with the ovaries, is a major procedure reserved for severe cases where other treatments have failed and childbearing is complete.¹⁰

Pain Management

Because endometriosis pain is complex—involving inflammation, nerve damage (neuropathic pain), and muscle tension—a multi-pronged approach is often best. This includes anti-inflammatory medications (NSAIDs), therapies targeting nerve pain, physical therapy, and complementary approaches like acupuncture and dietary changes.⁸, ¹¹

Limitations of Current Treatments

While helpful, today’s treatments have major drawbacks: they do not offer a cure, hormonal therapies have side effects and prevent pregnancy, and symptoms frequently recur after treatment stops.⁹ Critically, they all target the symptoms of the disease (pain and lesion growth) rather than its root causes—the developmental, epigenetic, and immune factors that drive it in the first place.²⁸

Conclusions: Towards a Holistic Understanding and Future Directions

The story of endometriosis has evolved from a simple mechanical theory to a sophisticated model of a complex, multifactorial disease. While Sampson's retrograde menstruation theory remains relevant for some pelvic cases, the Müllerianosis theory provides a more robust explanation for the disease's full scope, including its presence in distant organs and its familial nature.

This modern understanding—which integrates developmental origins with genetic, epigenetic, and immunological factors—clarifies why current treatments fall short. Hormonal therapies and surgery manage the downstream effects but do not correct the fundamental cellular and molecular errors. The high recurrence rates are a testament to this reality.

Future progress in treating endometriosis depends on shifting focus from symptoms to causes:

Targeting Fundamental Mechanisms: Research must develop drugs that can correct the underlying problems—for example, therapies that reverse abnormal epigenetic marks, restore proper immune function, or regulate the aberrant stem cells that may initiate lesions.
Personalized Medicine: Given the disease's complexity, a one-size-fits-all approach is inadequate. Future treatments should be tailored to an individual's unique genetic, epigenetic, and immune profile.
Early Diagnosis: Understanding the disease's developmental origins could lead to biomarkers that identify at-risk individuals early in life, potentially before symptoms even begin.
Integrated Care: The best management combines medical and surgical treatments with holistic support, including physical therapy, pain psychology, and nutritional guidance, to improve a patient's overall quality of life.

By embracing this multifaceted view and directing research toward its developmental origins and molecular drivers, the scientific community can finally move closer to developing truly curative treatments for the millions affected by endometriosis.

Sources

The evolutionary biology of endometriosis - PMC, accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8030264/
Global study shows the experience of Endometriosis is rooted in genetics, accessed June 6, 2025, https://www.ox.ac.uk/news/2023-03-14-global-study-shows-experience-endometriosis-rooted-genetics
Endometriosis: A New Perspective on Epigenetics and Oxidative Stress - ResearchGate, accessed June 6, 2025, https://www.researchgate.net/publication/389224402_Endometriosis_A_New_Perspective_on_Epigenetics_and_Oxidative_Stress
Association of endometriosis with Sjögren's syndrome: Genetic insights (Review), accessed June 6, 2025, https://www.spandidos-publications.com/10.3892/ijmm.2024.5344
Pathogenesis and Pathophysiology of Endometriosis - PMC, accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3836682/
Endometriosis | Embryo Project Encyclopedia, accessed June 6, 2025, https://embryo.asu.edu/pages/endometriosis
Endometriosis - StatPearls - NCBI Bookshelf, accessed June 6, 2025, https://www.ncbi.nlm.nih.gov/books/NBK567777/
Care and treatment of endometriosis pain - IFEM Endo, accessed June 6, 2025, https://www.institutendometriose.com/en/douleurs-chroniques-et-soins-daccompagnement/douleurs-chroniques/
Endometriosis: Causes, Symptoms, Diagnosis & Treatment - Cleveland Clinic, accessed June 6, 2025, https://my.clevelandclinic.org/health/diseases/10857-endometriosis
Endometriosis | Johns Hopkins Medicine, accessed June 6, 2025, https://www.hopkinsmedicine.org/health/conditions-and-diseases/endometriosis
Endometriosis & Lifestyle-Based Therapies | The Institute for Functional Medicine, accessed June 6, 2025, https://www.ifm.org/articles/endometriosis-root-causes-lifestyle-interventions
Endometriosis, a modern syndrome - PMC, accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3135985/
Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature) - PMC, accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8508982/
Flawed endometriosis research leads to decades of under-reporting of endometriosis-associated cancer risk - Worldwide EndoMarch, accessed June 6, 2025, https://endomarch.org/substantial-under-reporting-of-endometriosis-associated-cancer-risk-due-to-research-methodological-design-flaws/
Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways - PMC, accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4745121/
The Main Theories on the Pathogenesis of Endometriosis - PMC - PubMed Central, accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10001466/
Hormonal treatments for endometriosis: The endocrine background ..., accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9156507/
Ectopic endometrium in human foetuses is a common event and sustains the theory of müllerianosis in the pathogenesis of endometriosis, a disease that predisposes to cancer - PubMed Central, accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2671494/
Oxidative stress in endometriosis: Sources, mechanisms and therapeutic potential of antioxidants (Review) - Spandidos Publications, accessed June 6, 2025, https://www.spandidos-publications.com/10.3892/ijmm.2025.5513
Müllerian Lesions of the Bladder: Endometriosis, Endosalpingiosis ..., accessed June 6, 2025, https://www.cambridge.org/core/books/gynecologic-and-urologic-pathology/mullerian-lesions-of-the-bladder-endometriosis-endosalpingiosis-endocervicosis-and-mullerianosis/ED1509FF4BE2A1C5397A7395BA9B6388
Pericardial, pleural and diaphragmatic endometriosis in association with pelvic peritoneal and bowel endometriosis: a case report and review of the literature - PubMed Central, accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3516977/
Ronald Batt, MD - Mullerianosis: embryonic endometriosis, adenomyosis, endosalpingiosis, and endocervicosis, accessed June 6, 2025, https://www.endofound.org/ronald-batt-mullerianosis-embryonic-endometriosis-adenomyosis-endosalpingiosis-and-endocervicosis
Ronald Elmer Batt, MD, PHD - Endometriosis Foundation of America, accessed June 6, 2025, https://www.endofound.org/-/ronald-elmer-batt
In Memoriam: Ronald Elmer Batt MD. PhD. - Endometriosis Foundation of America, accessed June 6, 2025, https://www.endofound.org/in-memoriam-ronald-elmer-batt-md-phd
Müllerianosis: four developmental (embryonic) mullerian diseases, accessed June 6, 2025, https://pubmed.ncbi.nlm.nih.gov/23314961/
Genetics and Genomics of Endometriosis - PMC, accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4346178/
Genetics of Endometriosis | GLOWM, accessed June 6, 2025, https://www.glowm.com/section-view/heading/Genetics%20of%20Endometriosis/item/362
Theories on the Pathogenesis of Endometriosis - PMC - PubMed Central, accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4334056/
The Molecular and Cellular Mechanisms of Endometriosis: From ..., accessed June 6, 2025, https://www.mdpi.com/1422-0067/26/6/2458
Endometriosis: Epigenetics, Diet And Future Directions | Gynecologic Oncology Institute, accessed June 6, 2025, https://www.gynecologiconcologyinstitute.org/news/endometriosis/endometriosis-research/endometriosis-epigenetics-diet-and-future-directions/
How Epigenetics Influences Endometriosis Development - Rachael Haverland Site, accessed June 6, 2025, https://endoexcellencecenter.com/how-epigenetics-influences-endometriosis-development/
The Role of the Immune System in the Development of Endometriosis - PMC, accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9265783/
The Immune Aspects of Endometriosis: How Your Body's Defense System Plays a Role, accessed June 6, 2025, https://drseckin.com/the-immune-aspects-of-endometriosis-how-your-bodys-defense-system-plays-a-role/
Endometriosis: Molecular Pathophysiology and Recent Treatment ..., accessed June 6, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11280110/
Surgical Treatment of Endometriosis: Excision and Destruction, accessed June 6, 2025, https://www.brighamandwomens.org/obgyn/infertility-reproductive-surgery/endometriosis/surgical-treatment-of-endometriosis-excision-and-destruction
Endometriosis - World Health Organization (WHO), accessed June 6, 2025, https://www.who.int/news-room/fact-sheets/detail/endometriosis
Endometriosis: Causes, Complications, and Treatment - Healthline, accessed June 6, 2025, https://www.healthline.com/health/endometriosis
www.advancedgynaecologymelbourne.com.au, accessed June 6, 2025, https://www.advancedgynaecologymelbourne.com.au/endometriosis/causes#:~:text=Coelomic%20metaplasia,vaginal%20septum%2C%20bladder%20and%20bowel
Müllerianosis - Histol Histopathol, accessed June 6, 2025, https://www.hh.um.es/pdf/Vol_22/22_10/Batt-22-1161-1166-2007.pdf
Unveiling the Mechanisms of Pain in Endometriosis: Comprehensive Analysis of Inflammatory Sensitization and Therapeutic Potential - MDPI, accessed June 6, 2025, https://www.mdpi.com/1422-0067/26/4/1770
Medical Treatments for Endometriosis - Brigham and Women's Hospital, accessed June 6, 2025, https://www.brighamandwomens.org/obgyn/infertility-reproductive-surgery/endometriosis/medical-treatment-for-endometriosis
Surgical Treatment for Endometriosis - NYU Langone Health, accessed June 6, 2025, https://nyulangone.org/conditions/endometriosis/treatments/surgical-treatment-for-endometriosis

Tia Tackles